Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2019, Article ID 6741213, 4 pages
https://doi.org/10.1155/2019/6741213
Case Report

Turmeric Induced Liver Injury: A Report of Two Cases

1Department of Gastroenterology, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia
2Department of Gastroenterology and Liver Transplantation, The Austin Hospital, 145 Studley Road, Heidelberg, Melbourne, Victoria, Australia
3Central Clinical School, Monash University, The Alfred Hospital, 99 Commercial Road, Melbourne, Victoria, Australia
4Department of Pharmacy, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia
5Clinical Biochemistry Unit, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia
6Department of Forensic Medicine, Monash University, Melbourne, Australia
7Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
8Department of General Medicine, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia

Correspondence should be addressed to Raphael P. Luber; moc.liamg@rebulleahpar

Received 11 March 2019; Accepted 17 April 2019; Published 28 April 2019

Academic Editor: Sorabh Kapoor

Copyright © 2019 Raphael P. Luber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Chalasani, R. J. Fontana, and H. L. Bonkovsky, “Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States,” Gastroenterology, vol. 135, no. 6, pp. 1924–1934.e4, 2008. View at Publisher · View at Google Scholar
  2. G. Ostapowicz, R. J. Fontana, F. V. Schioødt et al., “Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States,” Annals of Internal Medicine, vol. 137, no. 12, pp. 947–954, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Smith, K. Kawa, V. Eckl et al., “Herbal supplement sales in US increase 7.7% in 2016,” HerbalGram, vol. 115, pp. 56–65, 2016. View at Google Scholar
  4. S. C. Gupta, S. Patchva, and B. B. Aggarwal, “Therapeutic roles of curcumin: lessons learned from clinical trials,” The AAPS Journal, vol. 15, no. 1, pp. 195–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. C. D. Lao, M. T. Ruffin IV, D. Normolle et al., “Dose escalation of a curcuminoid formulation,” BMC Complementary and Alternative Medicine, vol. 6, article 10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. T. Kurien, D. Danda, and R. H. Scofield, “Therapeutic potential of curcumin and curcumin analogues in rheumatology,” International Journal of Rheumatic Diseases, vol. 18, no. 6, pp. 591–593, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Cheifetz, R. Gianotti, R. Luber, and P. R. Gibson, “Complementary and alternative medicines used by patients with inflammatory bowel diseases,” Gastroenterology, vol. 152, no. 2, pp. 415–429.e15, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Danan and C. Benichou, “Causality assessment of adverse reactions to drugs—I: a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries,” Journal of Clinical Epidemiology, vol. 46, no. 11, pp. 1323–1330, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Pope, K. Weng Choy, O. H. Drummer, and H. G. Schneider, “Novel benzodiazepines (clonazolam and flubromazolam) identified in candy-like pills,” The Journal of Applied Laboratory Medicine, vol. 3, no. 1, pp. 48–55, 2018. View at Publisher · View at Google Scholar
  10. L. Braun and M. Cohen, Herbs and Natural Supplements, Volume 2: An Evidence-Based Guide, vol. 2, Elsevier Health Sciences, 2015.
  11. N. Pescosolido, R. Giannotti, A. M. Plateroti, A. Pascarella, and M. Nebbioso, “Curcumin: therapeutical potential in ophthalmology,” Planta Medica, vol. 80, no. 4, pp. 249–254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. D.-W. Zhang, M. Fu, S.-H. Gao, and J.-L. Liu, “Curcumin and diabetes: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 636053, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. S. S. R. Srinivas, “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers,” Planta Medica, vol. 64, no. 4, pp. 353–356, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. M. R. Adhvaryu, N. M. Reddy, and B. C. Vakharia, “Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach,” World Journal of Gastroenterology, vol. 14, no. 30, pp. 4753–4762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Rahmani, S. Asgary, G. Askari et al., “Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial,” Phytotherapy Research, vol. 30, no. 9, pp. 1540–1548, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Horev, Y. Ramot, and L. Klapholz, “Yellow feet in a patient with breast and thyroid carcinoma, due to oral intake of turmeric,” Drug Safety - Case Reports, vol. 2, no. 1, p. 4, 2015. View at Publisher · View at Google Scholar
  17. S.-W. Lee, S.-S. Nah, J.-S. Byon et al., “Transient complete atrioventricular block associated with curcumin intake,” International Journal of Cardiology, vol. 150, no. 2, pp. e50–e52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. J. Kim, D. J. Lewis, B. S. Dabaja, and M. Duvic, “Curcumin for the treatment of tumor-stage mycosis fungoides,” Dermatologic Therapy, vol. 30, no. 4, p. e12511, 2017. View at Publisher · View at Google Scholar
  19. J. Huber, R. Deshazo, D. Powell, K. Duffy, and C. Hull, “Erythema multiforme-like allergic contact dermatitis to turmeric essential oil,” Dermatitis, vol. 27, no. 6, pp. 385-386, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Gattoc, P. M. Frew, S. N. Thomas et al., “Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia,” Open Access Journal of Clinical Trials, vol. 9, pp. 1–10, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Lasoff, F. L. Cantrell, and B. T. Ly, “Death associated with intravenous turmeric (Curcumin) preparation,” Clinical Toxicology, vol. 56, no. 5, pp. 384-385, 2018. View at Publisher · View at Google Scholar · View at Scopus
  22. A. L. Lukefahr, S. McEvoy, C. Alfafara, and J. L. Funk, “Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use,” BMJ Case Reports, vol. 2018, 2018. View at Google Scholar · View at Scopus
  23. T. Sugiyama, J.-I. Nagata, A. Yamagishi et al., “Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450 isozymes in rats,” Life Sciences, vol. 78, no. 19, pp. 2188–2193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Zhang, T. M. C. Tan, and L.-Y. Lim, “Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats,” Drug Metabolism and Disposition, vol. 35, no. 1, pp. 110–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Nayeri, S. Wu, E. Adams et al., “Acute calcineurin inhibitor nephrotoxicity secondary to turmeric intake: a case report,” Transplantation Proceedings, vol. 49, no. 1, pp. 198–200, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. P. R. Holt, “Curcumin for inflammatory bowel disease: a caution,” Clinical Gastroenterology and Hepatology, vol. 14, no. 1, p. 168, 2016. View at Publisher · View at Google Scholar · View at Scopus